UBS Group’s Spindletop Health Acquisition Corp. Warrant SHCAW Stock Holding History

UBS Group’s Portfolio SHCAW Stock Details SHCAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,300	Closed	–	–	11594
2022 Q3	$0	Hold	2,300	–	–	﹤0.01%	11514
2022 Q2	$0	Buy	+2,300	New	+$354	﹤0.01%	11486

UBS Group's SHCAW Position: Q4 2022 in Review

UBS Group sold out of Spindletop Health Acquisition Corp. Warrant (SHCAW) in Q4 2022, closing a stake of 2,300 shares.

UBS Group first reported a position in SHCAW in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold SHCAW as of Q4 2022.

UBS Group reported no remaining Spindletop Health Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
UBS Group sold 2,300 Spindletop Health Acquisition Corp. Warrant shares in Q4 2022.
UBS Group first reported a position in Spindletop Health Acquisition Corp. Warrant in Q2 2022 and held it in 2 quarters.
UBS Group's Spindletop Health Acquisition Corp. Warrant position peaked at $0 in Q3 2022.
0 funds tracked by Wall St. Rank held Spindletop Health Acquisition Corp. Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.